OFF LABEL USE OF DEVICE

This adverse event was reported 1353 times

These drugs are most commonly taken by patients reporting OFF LABEL USE OF DEVICE:

# Drug Count
0 LEVONORGESTREL 560
1 DUPILUMAB 277
2 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 135
3 TIRZEPATIDE 99
4 ALBUTEROL SULFATE 43
5 ORAL SEMAGLUTIDE 30
6 METFORMIN 21
7 ALBUTEROL 20
8 METFORMIN ER 500 MG 18
9 METFORMIN ER 750 MG 18
See all common drugs associated with OFF LABEL USE OF DEVICE

OFF LABEL USE OF DEVICE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ESTRADIOL AND LEVONORGESTREL 14 0.0068
1 CERLIPONASE ALFA 3 0.0056
2 GLYCOPYRROLATE AND FORMOTEROL FUMARATE 9 0.0046
3 LEVONORGESTREL 560 0.0028
4 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 135 0.0014
5 NICARDIPINE HYDROCHLORIDE 3 0.0013
6 NICARDIPINE 4 0.0009
7 BACLOFEN INJECTION 2 0.0006
8 PEGFILGRASTIM 7 0.0006
9 TIRZEPATIDE 99 0.0005
See all drugs enriched for association with OFF LABEL USE OF DEVICE

OFF LABEL USE OF DEVICE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 2 0.0029
1 Progestin [EPC] 576 0.0020
2 Endoglycosidase [EPC] 1 0.0005
3 Interleukin-4 Receptor alpha Antagonist [EPC] 277 0.0005
4 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
5 Provitamin D2 Compound [EPC] 13 0.0004
6 Cytolytic Agent [EPC] 1 0.0004
7 Catechol-O-Methyltransferase Inhibitor [EPC] 2 0.0004
8 Androgen [EPC] 10 0.0004
9 TRPM8 Thermoreceptor Agonist [EPC] 2 0.0003
See all drug classes enriched for association with OFF LABEL USE OF DEVICE